Skip to main

Caladrius Biosciences

CLBS is nowLSTA
CLBS logo
This stock has changed its ticker name. This happens for a variety of reason, including a corporate merger or simply a change in company name.
Learn More
Go to the new stock page

Frequently Asked Questions (FAQ)

As of Jul 13, 2025, the market cap for CLBS stock is $23.31M

The current P/E ratio for CLBS stock is -1.18

The 52-week high for CLBS stock is $4.20. The current CLBS stock price $undefined is 100.00% below its 52-week high

The 52-week low for CLBS stock is $1.87. The current CLBS stock price $undefined has increased 100.00% from its 52-week low

No, the CLBS stock does not pay dividends to its shareholders

How to buy CLBS stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in CLBS stock

    Navigate to the Explore page. Then, type CLBS into the search bar. When you see CLBS stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased CLBS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Caladrius Biosciences Stock Earnings

The value each CLBS share was expected to gain vs. the value that each CLBS share actually gained.

Caladrius Biosciences (CLBS) reported Q2 2022 earnings per share (EPS) of -$0.11, missing estimates of -$0.10 by 10.00%. In the same quarter last year, Caladrius Biosciences's earnings per share (EPS) was -$0.10. Caladrius Biosciences is expected to release next earnings on 08/04/2022, with an earnings per share (EPS) estimate of $0.

Buy Caladrius Biosciences (CLBS) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.